ABUSCREEN ONLINE FOR COCAINE METABOLITE— 510(k) K924113

Substantially Equivalent

Roche Diagnostic Systems, Inc.

FDA 510(k) clearance K924113 for ABUSCREEN ONLINE FOR COCAINE METABOLITE, Substantially Equivalent on 1992-12-28. Applicant: Roche Diagnostic Systems, Inc..

Clearance details

Applicant: Roche Diagnostic Systems, Inc.
Product code: Code DLN
Advisory panel: Clinical Toxicology
Date received: 1992-08-13
Decision date: 1992-12-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Branchburg, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.